Prot #BHV7000-201: A Phase 2, Global, Multicenter, Long-Term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

Project: Research project

Project Details

StatusActive
Effective start/end date1/9/251/9/28

Funding

  • PPD Investigator Services, LLC (Prot #BHV7000-201 // Prot #BHV7000-201)
  • Biohaven Pharmaceuticals, Inc. (Prot #BHV7000-201 // Prot #BHV7000-201)